Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2019 / N 2

О некоторых ролях калия и магния в терапевтической практике
О.А. Громова, И.Ю. Торшин, А.Г. Калачева, Т.Р. Гришина, И.С. Сардарян, К.В. Рудаков, А.Н. Галустян

Список литературы

1. Громова О.А., Торшин И.Ю. Магний и «болезни цивилизации». Практическое руководство. М.: Гэотар-Медиа; 2018. 800 с.
2. Bailey RL, Pac SG, Fulgoni VL 3rd, Reidy KC, Catalano PM. Estimation of total usual dietary intakes of pregnant women in the United States. JAMA Network Open 2019 Jun 5;2(6):e195967.
3. Lutz LJ, Gaffney-Stomberg E, Karl JP, Hughes JM, Guerriere KI, McClung JP. Dietary intake in relation to military dietary reference values during army basic combat training; a multi-center, cross-sectional study. Military Medicine 2019 Mar;184(3-4):e223-30.
4. Beaudart C, Locquet M, Touvier M, Reginster JY, Bruyère O. Association between dietary nutrient intake and sarcopenia in the SarcoPhAge study. Aging Clinical and Experimental Research 2019 Jun;31(6):815-24.
5. Громова О.А., Калачева А.Г., Торшин И.Ю., Рудаков К.В., Грустливая У.Е., Юдина Н.В., Егорова Е.Ю., Лиманова О.А., Федотова Л.Э., Грачева О.Н., Никифорова Н.В., Сатарина Т.Е., Гоголева И.В., Гришина Т.Р., Курамшина Д.Б., Новикова Л.Б., Лисицына Е.Ю., Керимкулова Н.В., Владимирова И.С., Чекмарева М.Н. Лялякина Е.В., Шалаева Л.А., Талепоровская С.Ю., Силинг Т.Б., Прозорова Н.В., Семенов В.А., Семенова О.В., Назарова Н.А., Галустян А.Н., Сардарян И.С. Недостаточность магния – достоверный фактор риска коморбидных состояний: результаты крупномасштабного скрининга магниевого статуса в регионах России. Фарматека 2013;6(259):115-29.
6. Wu X, Ackermann U, Sonnenberg H. Hypertension development in Dahl S and R rats on high salt-low potassium diet: calcium, magnesium and sympathetic nervous system. Clinical and Experimental Hypertension (New York, N.Y.: 1993)1998 Oct;20(7):795-815.
7. Rubenowitz E, Landin K, Wilhelmsen L. Skeletal muscle magnesium and potassium by gender and hypertensive status. Scandinavian Journal of Clinical and Laboratory Investigation 1998 Feb;58(1):47-54.
8. Touyz RM, Milne FJ, Seftel HC, Reinach SG. Magnesium, calcium, sodium and potassium status in normotensive and hypertensive Johannesburg residents. South African Medical Journal 1987 Sep;72(6):377-81.
9. Afridi HI, Kazi TG, Kazi N, Jamali MK, Arain MB, Jalbani N, Sarfaraz RA, Shah A, Kandhro GA, Shah AQ, Baig JA. Potassium, calcium, magnesium, and sodium levels in biological samples of hypertensive and nonhypertensive diabetes mellitus patients. Biological Trace Element Research 2008 Sep;124(3):206-24.
10. Panhwar AH, Kazi TG, Afridi HI, Talpur FN, Arain S, Kazi N. Distribution of potassium, calcium, magnesium, and sodium levels in biological samples of Pakistani hypertensive patients and control subjects. Clinical Laboratory 2014;60(3):463-74.
11.Witteman JC, Grobbee DE, Derkx FH, Bouillon R, de Bruijn AM, Hofman A. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. The American Journal of Clinical Nutrition 1994 Jul;60(1):129-35.
12. Itoh K, Kawasaki T, Uezono K. [Relationship of dietary intake of sodium, potassium, calcium and magnesium to blood pressure]. Nihon Koshu Eisei Zasshi 1995 Feb;42(2):95-103.
13. Joosten MM, Gansevoort RT, Mukamal KJ, Kootstra-Ros JE, Feskens EJ, Geleijnse JM, Navis G, Bakker SJ; PREVEND Study Group. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension 2013 Jun;61(6):1161-7.
14. Юдина Н.В., Егорова Е.Ю., Гришина Т.Р., Калачева А.Г., Громова О.А. Сравнительная эффективность минеральной коррекции при лечении синдрома вегетативной дистонии у молодых в сочетании с артериальной гипотензией. Земский врач 2013;4:41-7.
15. Iqbal S, Klammer N, Ekmekcioglu C. The effect of electrolytes on blood pressure: a brief summary of meta-analyses. Nutrients 2019 Jun;11(6). pii: E1362.
16. Fischer PW, Giroux A. Effects of dietary magnesium on sodium-potassium pump action in the heart of rats. The Journal of Nutrition 1987 Dec;117(12):2091-5.
17. Knopf M, Valcin A, Yang TS, Goldson H, Levowitz BS. Potassium flux in the heart and its relation to magnesium iron. Bulletin of the New York Academy of Medicine 1971 Oct;47(10):1228.
18. Громова О.А., Калачева А.Г., Торшин И.Ю., Гришина Т.Р., Юдина Н.В. Калийсберегающие свойства магния. Кардиология 2013;53(10):38-48.
19. Ferdaus MZ, Mukherjee A, Nelson JW, Blatt PJ, Miller LN, Terker A, Staub O, Lin DH, McCormick JA. Mg2+ restriction downregulates NCC through NEDD4-2 and prevents its activation by hypokalemia. American Journal of Physiology. Renal Physiology 2019 Jul 31. doi: 10.1152/ajprenal.00216.2019. [Epub ahead of print].
20. The Collaborative Study Group for Multi-center Clinical Trial of Magnesium in Acute Myocardial Infarction. A multi-center randomized clinical trial to evaluate the efficacy of early administration of magnesium in acute myocardial infarction. Chinese Journal of Cardiology, 2002 Feb;30(2):82-7.
21. Reinhart RA, Broste SK, Spencer S, Marx JJ Jr, Haas RG, Rae P. Relation between magnesium and potassium concentrations in myocardium, skeletal muscle, and mononuclear blood cells. Clinical Chemistry 1992 Dec;38(12):2444-8.
22. Kafka H, Langevin L, Armstrong PW. Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. Archives of Internal Medicine 1987 Mar;147(3):465-9.
23. Khan AM, Lubitz SA, Sullivan LM, Sun JX, Levy D, Vasan RS, Magnani JW, Ellinor PT, Benjamin EJ, Wang TJ. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation 2013 Jan;127(1):33-8.
24. Misialek JR, Lopez FL, Lutsey PL, Huxley RR, Peacock JM, Chen LY, Soliman EZ, Agarwal SK, Alonso A. Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans – Atherosclerosis Risk in Communities (ARIC) study. Circulation Journal 2013;77(2):323-9.
25. Chiuve SE, Korngold EC, Januzzi JL Jr, Gantzer ML, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. The American Journal of Clinical Nutrition 2011;93(2):253-60.
26. Gurfinkel E, Pazos AA, Mautner B. Abnormal QT intervals associated with negative T waves induced by antiarrhythmic drugs are rapidly reduced using magnesium sulfate as an antidote. Clinical Cardiology 1993 Jan;16(1):35-8.
27. Bachman DM. Oral magnesium ion shortens prolonged QTc interval. The Journal of Clinical Psychiatry 2003 Jun;64(6):733-4.
28. McBride BF, Min B, Kluger J, Guertin D, Henyan NN, Coleman CI, Silver BB, White CM. An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence. Annals of Noninvasive Electrocardiology 2006 Apr;11(2):163-9.
29. Kurita T. Antiarrhythmic effect of parenteral magnesium on ventricular tachycardia associated with long QT syndrome. Magnesium Research 1994 Jun;7(2):155-7.
30. Whittaker JD, Downes F, Becker H, Garnham A, Wall M. Influence of perioperative serum magnesium for cardiac and noncardiac morbidity and mortality following emergency peripheral vascular surgery. Journal of Cardiothoracic and Vascular Anesthesia 2019 Feb;33(2):474-9.
31. Shiga T, Wajima Z, Inoue T, Ogawa R. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. The American Journal of Medicine 2004 Sep;117(5):325-33.
32. Trekova NA, Andrianova MIu, Tolstova IA, Aksel'rod BA, Zaitseva SV, Morozov IuA. [Use of a potassium and magnesium asparaginate solution to maintain the balance of potassium and magnesium during cardiosurgical interventions under extracorporeal circulation]. Anesteziologiia i Reanimatologiia 2008 Sep-Oct;(5):17-21.
33. Zhi YF, Huang YS, Xu BS, Wang SR. [Clinical investigation of the protective effects of potassium magnesium aspartate against arrhythmia and its possible anti-oxidative mechanism]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007 Nov;19(11):662-6.
34. Manz M, Susilo R. [Therapy of cardiac arrhythmias. Clinical significance of potassium- and magnesium aspartate in arrhythmias]. Fortschritte der Medizin. Originalien 2002;120(1):11-5.
35. Mancia G, Grassi G. Management of very elderly hypertensives: the HYVET study. Aging Clinical and Experimental Research 2008 Dec;20(6):494-5.
36. Hollifield JW. Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension. The American Journal of Medicine 1984 Nov;77(5A):28-32.
37. Ayad RF, Assar MD, Simpson L, Garner JB, Schussler JM. Causes and management of drug-induced long QT syndrome. Proceedings (Baylor University Medical Center) 2010 Jul;23(3):250-5.
38. Nagele P, Pal S, Brown F, Blood J, Miller JP, Johnston J. Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia. Anesthesiology 2012 Aug;117(2):321-38.
39. Trinkley KE, Page RL 2nd, Lien H, Yamanouye K, Tisdale JE. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Current Medical Research and Opinion 2013 Dec;29(12):1719-26.
40. Scorza FA, Albuquerque Md, Arida RM, Cysneiros RM. Serum levels of magnesium in sudden cardiac deaths among people with schizophrenia: hit or miss? Arquivos de Neuro-Psiquiatria 2012 Oct;70(10):814-6.
41. Fukai F, Murayama A. Association and dissociation of estrogen receptor with estrogen receptor-binding factors is regulated by Mg2+. The Journal of Biochemistry 1984 Apr;95(4):1227-30.
42. Torshin IYu, Gromova OA. Magnesium and pyridoxine: fundamental studies and clinical practice. New York: Nova Science Publishers; 2011. 175 p.
43. Meng Y, Sun J, Yu J, Wang C, Su J. Dietary intakes of calcium, iron, magnesium, and potassium elements and the risk of colorectal cancer: a meta-analysis. Biological Trace and Elements Research 2019 Jun;189(2):325-35.
44. Chinigarzadeh A, Muniandy S, Salleh N. Estrogen, progesterone, and genistein differentially regulate levels of expression of alpha-, beta-, and gamma-epithelial sodium channel (ENaC) and alpha-sodium potassium pump (Na+/K+-ATPase) in the uteri of sex steroid-deficient rats. Theriogenology 2015 Oct;84(6):911-26.
45. Громова О.А., Торшин И.Ю., Лиманова О.А., Громов А.Н., Керимкулова Н.В. Сравнительное исследование доказательной базы эффективности и безопасности применения пероральной и трансдермальной форм заместительной гормональной терапии эстрогенами у женщин в различные возрастные периоды. Проблемы репродукции 2013;19(6):86-96.
46. Громова О.А., Торшин И.Ю., Томилова И.К., Джиджихия Л.К., Керимкулова Н.В. Калий, магний и пиридоксин в контексте биологических эффектов эстрогенов. Гинекология 2017;19(3):30-9.
47. Pisarenko OI, Serebriakova LI, Tsikitishvili OV, Studneva IM. [Attenuation of irreversible rat heart injury by reperfusion with metabolic protectors]. Biomeditsinskaya Khimiya 2008;54(6):659-70.
48. Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnesium Research 2001 Dec;14(4):257-62.
49. Mühlbauer B, Schwenk M, Coram WM, Antonin KH, Etienne P, Bieck PR, Douglas FL. Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers. European Journal of Clinical Pharmacology 1991;40(4):437-8.
50. Wu G, Tian H, Han K, Xi Y, Yao Y, Ma A. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension. Clinical and Experimental Hypertension (New York, N.Y.: 1993) 2006 Jul;28(5):489-97.
51. Schuchardt JP, Hahn A. Intestinal absorption and factors influencing bioavailability of magnesium-an update. Current Nutrition & Food Science 2017 Nov;13(4):260-78.
52. Franzoni F, Santoro G, Carpi A, Da Prato F, Bartolomucci F, Femia FR, Prattichizzo F, Galetta F. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension. Biomedicine & Pharmacotherapy 2005 Jan-Feb;59(1-2):25-9.
53. Wirell MP, Wester PO, Stegmayr BG. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study. Journal of Internal Medicine 1994 Aug;236(2):189-95.
54. Dyckner T, Wester PO. Effect of magnesium on blood pressure. British Medical Journal (Clinical Research Edition) 1983 Jun;286(6381):1847-9.
55. Zhu L, Wang J, Wang Y, Jia L, Sun K, Wang H, Zou Y, Tian T, Liu Y, Zou J, Hui R, Yuan Z, Song L. Plasma uric acid as a prognostic marker in patients with hypertrophic cardiomyopathy. The Canadian Journal of Cardiology 2015 Oct;31(10):1252-8.
56. Cicero AF, Rosticci M, Tocci G, Bacchelli S, Urso R, D’Addato S, Borghi C. Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort. European Journal of Internal Medicine 2015 May;26(4):255-8.
57. Давидович И.М., Мостовский В.Ю., Кузнецова И.А., Скидан В.И. Панангин и хлорид калия: сравнительная эффективность при проведении нагрузочных фармакологических проб у пациентов молодого возраста с миокардиодистрофией. Вестник аритмологии 2000;16:50-3.
58. Крючкова Т.А., Барзасекова С.А., Романова Т.А., Петровская Т.Ю., Кириенко А.И. Клиническое значение применения панангина у детей с недифференцированными диспластическими заболеваниями соединительной ткани. Научные ведомости Белгородского государственного университета. Медицина. Фармация 2013;4(147):77-82.
59. Описание лекарственного препарата Панангин® (Panangin®). Основано на официально утвержденной инструкции по применению препарата и подготовлено для электронного издания справочника Видаль 2018 года, дата обновления: 03.13.2019. Доступно по: https://www.vidal.ru/drugs/panangin__642. Ссылка активна на 29.08.2019.

References

1. Gromova OA, Torshin IYu. Magnesium and "diseases of civilization". Practical guidelines. Moscow: Geotar-Media; 2018. 800 p. (In Russian).
2. Bailey RL, Pac SG, Fulgoni VL 3rd, Reidy KC, Catalano PM. Estimation of total usual dietary intakes of pregnant women in the United States. JAMA Network Open 2019 Jun 5;2(6):e195967.
3. Lutz LJ, Gaffney-Stomberg E, Karl JP, Hughes JM, Guerriere KI, McClung JP. Dietary intake in relation to military dietary reference values during army basic combat training; a multi-center, cross-sectional study. Military Medicine 2019 Mar;184(3-4):e223-30.
4. Beaudart C, Locquet M, Touvier M, Reginster JY, Bruyère O. Association between dietary nutrient intake and sarcopenia in the SarcoPhAge study. Aging Clinical and Experimental Research 2019 Jun;31(6):815-24.
5. Gromova OA, Kalacheva AG, Torshin IYu, Rudakov KV, Grustlivaya UE, Yudina NV, Egorova EYu, Limanowa OA, Fedotova LE, Gracheva ON, Nikiforova NV, Satarina TE, Gogoleva IV, Grishina TR, Kuramshina DB, Novikova LB, Lisitsyna EYu, Kerimkulova NV, Vladimirova IS, Chekmareva MN, Lyalyakina EV, Shalayeva LA, Taleporovskaya SYu, Siling TB, Prozorova NV, Semenov VA, Semenova OV, Nazarova NA, Galustyan AN, Sardaryan IS. Magnesium deficiency: a significant risk factor of comorbid conditions: results of a large-scale screening of magnesium status in the regions of Russia. Farmateka 2013;6(259):115-29 (In Russian).
6. Wu X, Ackermann U, Sonnenberg H. Hypertension development in Dahl S and R rats on high salt-low potassium diet: calcium, magnesium and sympathetic nervous system. Clinical and Experimental Hypertension (New York, N.Y.: 1993)1998 Oct;20(7):795-815.
7. Rubenowitz E, Landin K, Wilhelmsen L. Skeletal muscle magnesium and potassium by gender and hypertensive status. Scandinavian Journal of Clinical and Laboratory Investigation 1998 Feb;58(1):47-54.
8. Touyz RM, Milne FJ, Seftel HC, Reinach SG. Magnesium, calcium, sodium and potassium status in normotensive and hypertensive Johannesburg residents. South African Medical Journal 1987 Sep;72(6):377-81.
9. Afridi HI, Kazi TG, Kazi N, Jamali MK, Arain MB, Jalbani N, Sarfaraz RA, Shah A, Kandhro GA, Shah AQ, Baig JA. Potassium, calcium, magnesium, and sodium levels in biological samples of hypertensive and nonhypertensive diabetes mellitus patients. Biological Trace Element Research 2008 Sep;124(3):206-24.
10. Panhwar AH, Kazi TG, Afridi HI, Talpur FN, Arain S, Kazi N. Distribution of potassium, calcium, magnesium, and sodium levels in biological samples of Pakistani hypertensive patients and control subjects. Clinical Laboratory 2014;60(3):463-74.
11.Witteman JC, Grobbee DE, Derkx FH, Bouillon R, de Bruijn AM, Hofman A. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. The American Journal of Clinical Nutrition 1994 Jul;60(1):129-35.
12. Itoh K, Kawasaki T, Uezono K. [Relationship of dietary intake of sodium, potassium, calcium and magnesium to blood pressure]. Nihon Koshu Eisei Zasshi 1995 Feb;42(2):95-103.
13. Joosten MM, Gansevoort RT, Mukamal KJ, Kootstra-Ros JE, Feskens EJ, Geleijnse JM, Navis G, Bakker SJ; PREVEND Study Group. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension 2013 Jun;61(6):1161-7.
14. Yudina NV, Yegorova EYu, Grishina TR, Kalacheva AG, Gromova OA. Comparative efficacy of mineral correction in treatment of autonomic dystonia syndrome in young people with arterial hypotension. Zemskiy Vrach 2013;4:41-7 (In Russian).
15. Iqbal S, Klammer N, Ekmekcioglu C. The effect of electrolytes on blood pressure: a brief summary of meta-analyses. Nutrients 2019 Jun;11(6). pii: E1362.
16. Fischer PW, Giroux A. Effects of dietary magnesium on sodium-potassium pump action in the heart of rats. The Journal of Nutrition 1987 Dec;117(12):2091-5.
17. Knopf M, Valcin A, Yang TS, Goldson H, Levowitz BS. Potassium flux in the heart and its relation to magnesium iron. Bulletin of the New York Academy of Medicine 1971 Oct;47(10):1228.
18. Gromova OA, Kalacheva AG, Torshin IYu, Grishina TR, Yudina NV. Potassium-preserving properties of magnesium. Kardiologiia 2013;53(10):38-48 (In Russian).
19. Ferdaus MZ, Mukherjee A, Nelson JW, Blatt PJ, Miller LN, Terker A, Staub O, Lin DH, McCormick JA. Mg2+ restriction downregulates NCC through NEDD4-2 and prevents its activation by hypokalemia. American Journal of Physiology. Renal Physiology 2019 Jul 31. doi: 10.1152/ajprenal.00216.2019. [Epub ahead of print].
20. The Collaborative Study Group for Multi-center Clinical Trial of Magnesium in Acute Myocardial Infarction. A multi-center randomized clinical trial to evaluate the efficacy of early administration of magnesium in acute myocardial infarction. Chinese Journal of Cardiology, 2002 Feb;30(2):82-7.
21. Reinhart RA, Broste SK, Spencer S, Marx JJ Jr, Haas RG, Rae P. Relation between magnesium and potassium concentrations in myocardium, skeletal muscle, and mononuclear blood cells. Clinical Chemistry 1992 Dec;38(12):2444-8.
22. Kafka H, Langevin L, Armstrong PW. Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. Archives of Internal Medicine 1987 Mar;147(3):465-9.
23. Khan AM, Lubitz SA, Sullivan LM, Sun JX, Levy D, Vasan RS, Magnani JW, Ellinor PT, Benjamin EJ, Wang TJ. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation 2013 Jan;127(1):33-8.
24. Misialek JR, Lopez FL, Lutsey PL, Huxley RR, Peacock JM, Chen LY, Soliman EZ, Agarwal SK, Alonso A. Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans – Atherosclerosis Risk in Communities (ARIC) study. Circulation Journal 2013;77(2):323-9.
25. Chiuve SE, Korngold EC, Januzzi JL Jr, Gantzer ML, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. The American Journal of Clinical Nutrition 2011;93(2):253-60.
26. Gurfinkel E, Pazos AA, Mautner B. Abnormal QT intervals associated with negative T waves induced by antiarrhythmic drugs are rapidly reduced using magnesium sulfate as an antidote. Clinical Cardiology 1993 Jan;16(1):35-8.
27. Bachman DM. Oral magnesium ion shortens prolonged QTc interval. The Journal of Clinical Psychiatry 2003 Jun;64(6):733-4.
28. McBride BF, Min B, Kluger J, Guertin D, Henyan NN, Coleman CI, Silver BB, White CM. An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence. Annals of Noninvasive Electrocardiology 2006 Apr;11(2):163-9.
29. Kurita T. Antiarrhythmic effect of parenteral magnesium on ventricular tachycardia associated with long QT syndrome. Magnesium Research 1994 Jun;7(2):155-7.
30. Whittaker JD, Downes F, Becker H, Garnham A, Wall M. Influence of perioperative serum magnesium for cardiac and noncardiac morbidity and mortality following emergency peripheral vascular surgery. Journal of Cardiothoracic and Vascular Anesthesia 2019 Feb;33(2):474-9.
31. Shiga T, Wajima Z, Inoue T, Ogawa R. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. The American Journal of Medicine 2004 Sep;117(5):325-33.
32. Trekova NA, Andrianova MIu, Tolstova IA, Aksel'rod BA, Zaitseva SV, Morozov IuA. [Use of a potassium and magnesium asparaginate solution to maintain the balance of potassium and magnesium during cardiosurgical interventions under extracorporeal circulation]. Anesteziologiia i Reanimatologiia 2008 Sep-Oct;(5):17-21.
33. Zhi YF, Huang YS, Xu BS, Wang SR. [Clinical investigation of the protective effects of potassium magnesium aspartate against arrhythmia and its possible anti-oxidative mechanism]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007 Nov;19(11):662-6.
34. Manz M, Susilo R. [Therapy of cardiac arrhythmias. Clinical significance of potassium- and magnesium aspartate in arrhythmias]. Fortschritte der Medizin. Originalien 2002;120(1):11-5.
35. Mancia G, Grassi G. Management of very elderly hypertensives: the HYVET study. Aging Clinical and Experimental Research 2008 Dec;20(6):494-5.
36. Hollifield JW. Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension. The American Journal of Medicine 1984 Nov;77(5A):28-32.
37. Ayad RF, Assar MD, Simpson L, Garner JB, Schussler JM. Causes and management of drug-induced long QT syndrome. Proceedings (Baylor University Medical Center) 2010 Jul;23(3):250-5.
38. Nagele P, Pal S, Brown F, Blood J, Miller JP, Johnston J. Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia. Anesthesiology 2012 Aug;117(2):321-38.
39. Trinkley KE, Page RL 2nd, Lien H, Yamanouye K, Tisdale JE. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Current Medical Research and Opinion 2013 Dec;29(12):1719-26.
40. Scorza FA, Albuquerque Md, Arida RM, Cysneiros RM. Serum levels of magnesium in sudden cardiac deaths among people with schizophrenia: hit or miss? Arquivos de Neuro-Psiquiatria 2012 Oct;70(10):814-6.
41. Fukai F, Murayama A. Association and dissociation of estrogen receptor with estrogen receptor-binding factors is regulated by Mg@2+. The Journal of Biochemistry 1984 Apr;95(4):1227-30.
42. Torshin IYu, Gromova OA. Magnesium and pyridoxine: fundamental studies and clinical practice. New York: Nova Science Publishers; 2011. 175 p.
43. Meng Y, Sun J, Yu J, Wang C, Su J. Dietary intakes of calcium, iron, magnesium, and potassium elements and the risk of colorectal cancer: a meta-analysis. Biological Trace and Elements Research 2019 Jun;189(2):325-35.
44. Chinigarzadeh A, Muniandy S, Salleh N. Estrogen, progesterone, and genistein differentially regulate levels of expression of alpha-, beta-, and gamma-epithelial sodium channel (ENaC) and alpha-sodium potassium pump (Na@+/K@+-ATPase) in the uteri of sex steroid-deficient rats. Theriogenology 2015 Oct;84(6):911-26.
45. Gromova OA, Torshin IYu, Limanova OA, Gromov AN, Kerimkulova NV. Comparative study of evidence based data concerning efficacy and safety of oral and transdermal estrogen replacement therapy in women of different age. Russian Journal of Human Reproduction 2013;19(6):86-96 (In Russian).
46. Gromova OA, Torshin IYu, Tomilova IK, Jijikhiya LK, Kerimkulova NV. Potassium, magnesium and pyridoxine in context of biological effects of estrogens. Gynecology 2017;19(3):30-9 (In Russian).
47. Pisarenko OI, Serebriakova LI, Tsikitishvili OV, Studneva IM. [Attenuation of irreversible rat heart injury by reperfusion with metabolic protectors]. Biomeditsinskaya Khimiya 2008;54(6):659-70.
48. Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnesium Research 2001 Dec;14(4):257-62.
49. Mühlbauer B, Schwenk M, Coram WM, Antonin KH, Etienne P, Bieck PR, Douglas FL. Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers. European Journal of Clinical Pharmacology 1991;40(4):437-8.
50. Schuchardt JP, Hahn A. Intestinal absorption and factors influencing bioavailability of magnesium-an update. Current Nutrition & Food Science 2017 Nov;13(4):260-78.
51. Wu G, Tian H, Han K, Xi Y, Yao Y, Ma A. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension. Clinical and Experimental Hypertension (New York, N.Y.: 1993) 2006 Jul;28(5):489-97.
52. Franzoni F, Santoro G, Carpi A, Da Prato F, Bartolomucci F, Femia FR, Prattichizzo F, Galetta F. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension. Biomedicine & Pharmacotherapy 2005 Jan-Feb;59(1-2):25-9.
53. Wirell MP, Wester PO, Stegmayr BG. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study. Journal of Internal Medicine 1994 Aug;236(2):189-95.
54. Dyckner T, Wester PO. Effect of magnesium on blood pressure. British Medical Journal (Clinical Research Edition) 1983 Jun;286(6381):1847-9.
55. Zhu L, Wang J, Wang Y, Jia L, Sun K, Wang H, Zou Y, Tian T, Liu Y, Zou J, Hui R, Yuan Z, Song L. Plasma uric acid as a prognostic marker in patients with hypertrophic cardiomyopathy. The Canadian Journal of Cardiology 2015 Oct;31(10):1252-8.
56. Cicero AF, Rosticci M, Tocci G, Bacchelli S, Urso R, D’Addato S, Borghi C. Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort. European Journal of Internal Medicine 2015 May;26(4):255-8.
57. Davidovich IM, Mostovskiy VJu, Kuznetsova IA, Skidan VI. Panangin and potassium chloride: comparative efficacy during pharmacological load testing in young patients with myocardial. Journal of Arrithmology 2000;16:50-3 (In Russian).
58. Kryuchkova TA, Barzasekova SA, Romanova TA, Petrovskaya TYu, Kiriyenko AI. Clinical significance of panangin in children with undifferentiated connective tissue dysplasia. Belgorod State University Scientific Bulletin. Medicine. Pharmacy 2013;4(147):77-82 (In Russian).
59. Panangin® description. Based on approved instructions for use and prepared for electronic publication in reference book "Vidal" 2018. Last update: 2019 Mar 13. Available from: https://www.vidal.ru/drugs/panangin__642 Accessed 2019 Aug 28. (In Russian).
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]